Equity Analysis /
United States of America

US : ANI Pharmaceuticals, Inc. - ANIP | 4Q21 First Look: Results Mixed as Pricing and Mix Weigh On Initial 2022 Outlook Ex-Cortrophin

    Michael Parolari
    Michael Parolari

    Research Associate

    CGS-CIMB
    25 March 2022
    Published by